Doo Yeon Kim

Affiliations: 
Neurology Harvard Medical School - Massachusetts General Hospital 
Google:
"Doo Kim"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kim E, Kim H, Jedrychowski MP, et al. (2023) Irisin reduces amyloid-β by inducing the release of neprilysin from astrocytes following downregulation of ERK-STAT3 signaling. Neuron
Jorfi M, Park J, Hall CK, et al. (2023) Infiltrating CD8 T cells exacerbate Alzheimer's disease pathology in a 3D human neuroimmune axis model. Nature Neuroscience
Boyarko B, Podvin S, Greenberg B, et al. (2023) Evaluation of bumetanide as a potential therapeutic agent for Alzheimer's disease. Frontiers in Pharmacology. 14: 1190402
Wittrahm R, Takalo M, Kuulasmaa T, et al. (2023) Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models. Neurobiology of Disease. 106140
Hebisch M, Klostermeier S, Wolf K, et al. (2023) The Impact of the Cellular Environment and Aging on Modeling Alzheimer's Disease in 3D Cell Culture Models. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2205037
Ning S, Jorfi M, Patel SR, et al. (2022) Neurotechnological Approaches to the Diagnosis and Treatment of Alzheimer's Disease. Frontiers in Neuroscience. 16: 854992
Kim JJ, Jorfi M, Tanzi RE, et al. (2021) Patterning of interconnected human brain spheroids. Lab On a Chip
Chun H, Im H, Kang YJ, et al. (2020) Severe reactive astrocytes precipitate pathological hallmarks of Alzheimer's disease via HO production. Nature Neuroscience
Cenini G, Hebisch M, Iefremova V, et al. (2020) Dissecting Alzheimer's disease pathogenesis in human 2D and 3D models. Molecular and Cellular Neurosciences. 103568
Kwak SS, Washicosky KJ, Brand E, et al. (2020) Amyloid-β42/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer's disease. Nature Communications. 11: 1377
See more...